Home › Research › Topics › early-markers
early-markers
3 studies tagged early-markers, dated 2014-01-01 to 2021-10-14. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declines 2021-10-14
- Apathy and anxiety are early markers of Alzheimer's disease 2019-10-19
- Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease 2014-01-01
Studies
3 studies carry this tag.
Date range
2014 to 2021
Top journals
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- Journal of Alzheimer's disease : JAD 1
- Neurobiology of aging 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Despite assumptions that cognitive changes invariably follow biomarker changes, early neuropsychological difficulties may emerge before/concurrently with plasma p-tau181 changes.
-
In this study, we investigated associations between neuropsychiatric symptoms (i.e., apathy, anxiety, and depression) and cerebral atrophy, white matter lesions (WML), beta-amyloid (Aβ) deposition, and cognitive decline in a nondemented sample. 104 cognitively unimpaired and 53 subjects with mild cognitive impairment were followed for up to 4 years within the Swedish BioFINDER study.
-
41/100
It has been demonstrated that peripheral injection of anti-amyloid-β (Aβ) antibodies to patients with Alzheimer's disease (AD) and AD transgenic mice facilitate Aβ clearance.